🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
TPS
$TPST
🔒 US EquitiesTempest Therapeutics Inc
AVG HISTORICAL GAP
+0.92%
MAX GAP RECORD
+22.34%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $TPST
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$TPST
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 14, 2026 Earnings Release 2026-08-14 (AFTER CLOSE) |
+7.39%
|
| May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE) |
+3.80%
|
| Nov 05, 2025 Earnings Release 2025-11-05 (BEFORE OPEN) |
+0.33%
|
| Aug 11, 2025 Earnings Release 2025-08-11 (AFTER CLOSE) |
-3.75%
|
| May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE) |
-1.91%
|
| Mar 27, 2025 Earnings Release 2025-03-27 (AFTER CLOSE) |
-5.95%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
-13.33%
|
| Aug 08, 2024 Earnings Release 2024-08-08 (AFTER CLOSE) |
+2.99%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
6.2%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (1)
📖 Intelligence Summary
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗